スポンサーリンク
Department of Obstetrics and Gynecology, Kurume University School of Medicine | 論文
- THERAPEUTIC EFFICACY OF CYTOTOXIC COMBINATION CHEMOTHERAPY IN OVARIAN "MATURE" TERATOMA
- DEVELOPMENT OF OVARIAN TUMORS EXPERIMENTALLY STUDIED IN MICE BY ^Co-RAY IRRADIATION
- Ovarian neuroblastoma due to malignant transformation of mature cystic teratoma : A clinicopathologic and immunohistologic analysis
- Serial evaluation for myocardial performance in fetuses and neonates using a new Doppler index
- Expression of Tumor-rejection Antigens in Gynecologic Cancers
- The Behavior of Endometrial Hyperplasia : A Prospective Study
- Paclitaxel-cisplatin combination in advaced ovarian cancer: a phase II study
- Fertility-preserving treatment for patients with malignant germ cell tumors of the ovary
- ANTITUMOR ACTIVITY OF CISPLATIN ANALOGS AGAINST MALIGNANT OVARIAN TUMOR XENOGRAFTS INTO NUDE MICE
- THE CURRENT THERAPEUTIC APPROACHES TO ADVANCED OVARIAN CANCER
- MALIGNANT DEGENERATION OF BENIGN CYSTIC TERATOMAS OF THE OVARY
- IFOSFAMIDE, ADRIAMYCIN AND CISPLATIN (IAP) PLUS BLEOMYCIN (B) COMBINATION CHEMOTHERAPY FOR PATIENTS WITH RECURRENT CANCER OF THE UTERINE CERVIX
- A PRELIMINARY STUDY OF A COMBINATION CHEMOTHERAPY WITH IFOSFAMIDE, ADRIAMYCIN AND CISPLATIN FOR ENDOMETRIAL CARCINOMA
- CISPLATIN, ADRIAMYCIN AND IFOSFAMIDE-BASED COMBINATION CHEMOTHERAPY FOR GYNECOLOGICAL CANCERS DERIVED FROM THE EXTENDED MULLERIAN SYSTEM
- Comparison of the Anterior Colporrhaphy Procedure and the Marshall-Marchetti-Krantz Operation in the Treatment of Stress Urinary Incontinence among Women
- CHEMOTHERAPY OF MALIGNANT OVARIAN TUMORS; THERAPEUTIC RESULTS OF IFOSFAMIDE
- ESTABLISHMENT AND MORPHOLOGIC CHARACTERIZATION OF CELL LINE (DMBA-OC-1) FROM 7,12- DIMETHYLBENZ (a) ANTHRACENE-INDUCED RAT OVARIAN CARCINOMA
- Evidence-based guidelines for treatment of cervical cancer in Japan : Japan Society of Gynecologic Oncology (JSGO) 2007 edition
- CHARACTERIZATION OF TRANSPLANT GENERATIONS OF PRIMARY RAT ADENOCARCINOMA AND SOME CHEMOTHERAPEUTIC OBSERVATIONS
- IS-30 Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy(Group4 Oncology2,International Session)